Zevra Therapeutics (ZVRA) Leases: 2014-2025
Historic Leases for Zevra Therapeutics (ZVRA) over the last 7 years, with Sep 2025 value amounting to $1.3 million.
- Zevra Therapeutics' Leases rose 63.05% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 63.05%. This contributed to the annual value of $1.0 million for FY2024, which is negligibly% changed negligibly from last year.
- Per Zevra Therapeutics' latest filing, its Leases stood at $1.3 million for Q3 2025, which was down 10.63% from $1.5 million recorded in Q2 2025.
- Zevra Therapeutics' 5-year Leases high stood at $1.6 million for Q1 2025, and its period low was $698,000 during Q3 2023.
- For the 3-year period, Zevra Therapeutics' Leases averaged around $1.1 million, with its median value being $1.0 million (2024).
- In the last 5 years, Zevra Therapeutics' Leases plummeted by 34.64% in 2023 and then skyrocketed by 64.22% in 2025.
- Quarterly analysis of 5 years shows Zevra Therapeutics' Leases stood at $1.1 million in 2021, then dropped by 13.41% to $988,000 in 2022, then climbed by 4.35% to $1.0 million in 2023, then remained steady at $1.0 million in 2024, then skyrocketed by 63.05% to $1.3 million in 2025.
- Its last three reported values are $1.3 million in Q3 2025, $1.5 million for Q2 2025, and $1.6 million during Q1 2025.